158 related articles for article (PubMed ID: 37051625)
21. Cellular senescence-related gene signature as a valuable predictor of prognosis in hepatocellular carcinoma.
Zhang S; Zheng Y; Li X; Zhang S; Hu H; Kuang W
Aging (Albany NY); 2023 Apr; 15(8):3064-3093. PubMed ID: 37059592
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma.
Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY
Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063
[TBL] [Abstract][Full Text] [Related]
23. Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.
Zhou Y; Li X; Long G; Tao Y; Zhou L; Tang J
Front Immunol; 2022; 13():994259. PubMed ID: 36341373
[TBL] [Abstract][Full Text] [Related]
24. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
[TBL] [Abstract][Full Text] [Related]
26. Prognostic analysis of tumor mutation burden and immune infiltration in hepatocellular carcinoma based on TCGA data.
Liu S; Tang Q; Huang J; Zhan M; Zhao W; Yang X; Li Y; Qiu L; Zhang F; Lu L; He X
Aging (Albany NY); 2021 Apr; 13(8):11257-11280. PubMed ID: 33820866
[TBL] [Abstract][Full Text] [Related]
27. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma.
Xu J; Shen X; Zhang B; Su R; Cui M; Yan L; Cao Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34386813
[TBL] [Abstract][Full Text] [Related]
29. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
[TBL] [Abstract][Full Text] [Related]
30. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
Luo Y; Liu H; Fu H; Ding GS; Teng F
Front Immunol; 2022; 13():974377. PubMed ID: 36458010
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
32. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
[TBL] [Abstract][Full Text] [Related]
33. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
[TBL] [Abstract][Full Text] [Related]
34. Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.
Dong RZ; Yang X; Zhang XY; Gao PT; Ke AW; Sun HC; Zhou J; Fan J; Cai JB; Shi GM
J Cell Mol Med; 2019 May; 23(5):3369-3374. PubMed ID: 30784182
[TBL] [Abstract][Full Text] [Related]
35. Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma.
Guo H; Zhang S; Zhang B; Shang Y; Liu X; Wang M; Wang H; Fan Y; Tan K
Front Immunol; 2023; 14():1202324. PubMed ID: 37457742
[TBL] [Abstract][Full Text] [Related]
36. Normal tissue adjacent to tumor expression profile analysis developed and validated a prognostic model based on Hippo-related genes in hepatocellular carcinoma.
Pan Q; Qin F; Yuan H; He B; Yang N; Zhang Y; Ren H; Zeng Y
Cancer Med; 2021 May; 10(9):3139-3152. PubMed ID: 33818013
[TBL] [Abstract][Full Text] [Related]
37. Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma.
Li N; Ren SH; Qin YF; Shao B; Qin H; Wang Z; Wang HD; Li GM; Zhu YL; Sun CL; Zhang JY; Shi GG; An XW; Wang H
Biomed Res Int; 2022; 2022():2680110. PubMed ID: 35782053
[TBL] [Abstract][Full Text] [Related]
38. Comparison of various approaches to combine logistic regression with genetic algorithms in survival prediction of hepatocellular carcinoma.
Książek W; Gandor M; Pławiak P
Comput Biol Med; 2021 Jul; 134():104431. PubMed ID: 34015670
[TBL] [Abstract][Full Text] [Related]
39. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironment.
Wang J; Lou J; Fu L; Jin Q
J Int Med Res; 2021 Feb; 49(2):300060520980646. PubMed ID: 33567957
[TBL] [Abstract][Full Text] [Related]
40. Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning.
Hasan MAM; Maniruzzaman M; Shin J
Sci Rep; 2023 Mar; 13(1):3771. PubMed ID: 36882493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]